218 related articles for article (PubMed ID: 15012784)
1. Evaluation of the 13C-triolein breath test for fat malabsorption in adult patients with cystic fibrosis.
Ritz MA; Fraser RJ; Di Matteo AC; Greville H; Butler R; Cmielewski P; Davidson G
J Gastroenterol Hepatol; 2004 Apr; 19(4):448-53. PubMed ID: 15012784
[TBL] [Abstract][Full Text] [Related]
2. Preliminary report of the (13)C-mixed triglyceride breath test to assess timing of pancreatic enzyme replacement therapy in children with cystic fibrosis.
van der Haak N; Boase J; Davidson G; Butler R; Miller M; Kaambwa B; Kritas S
J Cyst Fibros; 2016 Sep; 15(5):669-74. PubMed ID: 27102891
[TBL] [Abstract][Full Text] [Related]
3. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids.
Kalivianakis M; Minich DM; Bijleveld CM; van Aalderen WM; Stellaard F; Laseur M; Vonk RJ; Verkade HJ
Am J Clin Nutr; 1999 Jan; 69(1):127-34. PubMed ID: 9925134
[TBL] [Abstract][Full Text] [Related]
4. 13C mixed triglyceride breath test: a noninvasive method to assess lipase activity in children.
van Dijk-van Aalst K; Van Den Driessche M; van Der Schoor S; Schiffelers S; van't Westeinde T; Ghoos Y; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2001 May; 32(5):579-85. PubMed ID: 11429520
[TBL] [Abstract][Full Text] [Related]
5. Relation between pancreatic lipase activity and gastric emptying rate in children with cystic fibrosis.
Symonds EL; Omari TI; Webster JM; Davidson GP; Butler RN
J Pediatr; 2003 Dec; 143(6):772-5. PubMed ID: 14657826
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride oxidation in cystic fibrosis: a comparison between different 13C-labeled tracer substances.
Wutzke KD; Radke M; Breuel K; Gurk S; Lafrenz JD; Heine WE
J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):148-54. PubMed ID: 10435651
[TBL] [Abstract][Full Text] [Related]
7. 14C-triolein breath test as a rapid and convenient screening test for fat malabsorption.
Einarsson K; Björkhem I; Eklöf R; Blomstrand R
Scand J Gastroenterol; 1983 Jan; 18(1):9-12. PubMed ID: 6675178
[TBL] [Abstract][Full Text] [Related]
8. Combined single day 14C-triolein breath test and PABA test in the diagnosis of malabsorption.
Fleming SC; Kapembwa MS; Griffin GE
Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():50-5. PubMed ID: 2106821
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: trioctanoin, triolein, and palmitic acid breath tests.
Watkins JB; Klein PD; Schoeller DA; Kirschner BS; Park R; Perman JA
Gastroenterology; 1982 May; 82(5 Pt 1):911-7. PubMed ID: 7060913
[TBL] [Abstract][Full Text] [Related]
10. 13C and H2 breath tests to study extent and site of starch digestion in children with cystic fibrosis.
Amarri S; Harding M; Coward WA; Evans TJ; Weaver LT
J Pediatr Gastroenterol Nutr; 1999 Sep; 29(3):327-31. PubMed ID: 10468000
[TBL] [Abstract][Full Text] [Related]
11. Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis.
Stallings VA; Mondick JT; Schall JI; Barrett JS; Wilson M; Mascarenhas MR
Int J Clin Pharmacol Ther; 2013 Apr; 51(4):263-73. PubMed ID: 23357842
[TBL] [Abstract][Full Text] [Related]
12. Monitoring pancreatin supplementation in cystic fibrosis patients with the 13C-Hiolein breath test: evidence for normalized fat assimilation with high dose pancreatin therapy.
Braden B; Picard H; Caspary WF; Posselt HG; Lembcke B
Z Gastroenterol; 1997 Feb; 35(2):123-9. PubMed ID: 9066102
[TBL] [Abstract][Full Text] [Related]
13. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
14. Lipid digestion in cystic fibrosis: comparison of conventional and high-lipase enzyme therapy using the mixed-triglyceride breath test.
De Boeck K; Delbeke I; Eggermont E; Veereman-Wauters G; Ghoos Y
J Pediatr Gastroenterol Nutr; 1998 Apr; 26(4):408-11. PubMed ID: 9552136
[TBL] [Abstract][Full Text] [Related]
15. Bulk and compound specific analysis of stool lipid confirm that the "missing" 13C in the mixed triacylglycerol breath test is not in the stool.
Slater C; Ling S; Preston T; Weaver L
Food Nutr Bull; 2002 Sep; 23(3 Suppl):48-52. PubMed ID: 12362811
[TBL] [Abstract][Full Text] [Related]
16. Triolein breath test of fat absorption in patients with chronic liver disease.
Absalom SR; Saverymuttu SH; Maxwell JD; Levin GE
Dig Dis Sci; 1988 May; 33(5):565-9. PubMed ID: 3359910
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of the 14C-Triolein Breath Test: a critical analysis.
Butler RN; Gehling NJ; Lawson MJ; Grant AK
Aust N Z J Med; 1984 Apr; 14(2):111-3. PubMed ID: 6591903
[TBL] [Abstract][Full Text] [Related]
18. 13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis.
Amarri S; Harding M; Coward WA; Evans TJ; Weaver LT
Arch Dis Child; 1997 Apr; 76(4):349-51. PubMed ID: 9166030
[TBL] [Abstract][Full Text] [Related]
19. Exocrine pancreatic insufficiency: accuracy and clinical value of the uniformly labelled 13C-Hiolein breath test.
Lembcke B; Braden B; Caspary WF
Gut; 1996 Nov; 39(5):668-74. PubMed ID: 9026480
[TBL] [Abstract][Full Text] [Related]
20. Improving the specificity of the [13C]mixed triacylglycerol breath test by estimating carbon dioxide production from heart rate.
Slater C; Preston T; Weaver LT
Eur J Clin Nutr; 2006 Nov; 60(11):1245-52. PubMed ID: 16736067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
